Of note, results of following cellular functional assays confirmed that CES2 knockdown enhanced cell proliferation, repressed cell apoptosis and suppressed cell cycle arrest in S phase, which reversed the synergistic effect of GDNT and MMF on lung cancer cells (Fig. 5F-6C, p < 0.001). The gene discussed is CES2; the disease is lung cancer.